期刊文献+

急性冠脉综合征患者血清PAPP-A和IL-18的临床表达与相关性分析 被引量:3

Clinical expression of PAPP A and IL-18 and correlation analysis in acute coronary syndrome
下载PDF
导出
摘要 目的:观察妊娠相关蛋白酶-A(PAPP-A)和白介素-18(IL-18)在急性冠脉综合征(ACS)中的变化及其相关性。方法:60例经冠状动脉造影证实的冠心病患者,其中稳定性心绞痛组20例、急性心肌梗死组20例、不稳定性心绞痛组20例。另选20例正常健康人为对照组,采用酶联免疫吸附法(ELISA)检测血浆PAPP-A水平。结果:在ACS患者中,血清PAPP-A和IL-18水平明显高于SAP及正常人水平(P<0.01),PAPP-A与IL-18水平呈显著正相关(r2=0.881,P<0.01)。结论:ACS患者PAPP-A、IL-18升高,提示两者均可作为急性冠脉综合征预测预后的新的敏感的标志物。ACS组PAPP-A与IL-18水平呈显著正相关(r2=0.881,P<0.01)。 Objective:To observe the relationship between pregnancy--associated plasma protein-A (PAPP -A) and interleukin -18 (IL-18) in the patients with acute coronary syndrome (ACS). Methods:Sixty patients with coronary heart disease, who were diagnosed by angiography, were enrolled in this study, In which 20 patients with stable angina, 20 patients with acute myocardial infarction, and 20 patients with unstable angina, and at the same time, randomly selective 20 healthy subjects served as control group. Serum PAPP -A and IL-18 levels were measured by using untrasensitive immunosorbent assay (ELISA). Results:The plasma levels of PAPP - A and IL-18 were significantly higher in ACS patients than those in SAP and control group (P 〈 0.01). The significant correlation can be observed between the serum PAPP--A and IL--18 levels in ACS group (r2 = 0. 881,P 〈 0.01). Conclusion:The plasma levels of PAPP - A and CRP are increased in ACS patients , suggesting the clinical prediction values of both as new sensitive markers in the prognosis of ACS. A significant positive correlation can be observed between the serum PAPP--A and IL-18 levels in ACS group (r2=0. 881,P 〈 0.01).
出处 《黑龙江医药科学》 2011年第6期11-12,共2页 Heilongjiang Medicine and Pharmacy
关键词 妊娠相关血浆蛋白A 白介素-18 急性冠脉综合征 pregnancy-- associated plasma protein A (PAPP-- A) interleukin - 18 (IL- 18) acute coro-nary syndrome (ACS)
  • 相关文献

参考文献5

  • 1田彩霞,李艳,夏尊恩,陈元秀.急性冠脉综合征患者血浆炎性标志物及血脂水平分析[J].微循环学杂志,2006,16(2):46-48. 被引量:15
  • 2Blankenberg S, Tiret L, Bickel C. Interleukin-- 18 is a strong predic- tor of cardiovascular death in stable and unstable angina[J]. Circula- tion, 2002, 106(1): 24-30.
  • 3Consuegra--Sanchez L, Fredericks S, Kaski JC. Pregnancy--asso- ciated plasma protein-- A (PAPP-- A) and cardiovascular risk [J]. Athercssclerosis, 2009,203:346-352.
  • 4Conover CA, Harrington SC, Bale LK, et al. Surface association of pregnancy--associated plasma protein--A accounts for its colocalizat -- ion with activated macrophages [J ]. Am J Physiol Heart Circ Physiol, 2007, 292:994-1000.
  • 5Blankenberg S, Luc G, Dueimetiere P, et al. Interleukin-- 18 and theRisk of Coronary Heart Disease in European Men.. The Prospec- tive Epidemiological Study of Myocardial Infarction (PRIME)[J]. Circulation, 2003, 108(20):2453-2459.

二级参考文献1

共引文献14

同被引文献32

  • 1田彩霞,周传辉,管学平,颜敏,陈鑫,李莲,刘堂鑫.急性冠脉综合征患者PAPP-A基因IVS6+95(C/G)多态性与血浆PAPP-A水平及斑块性质的相关性[J].氨基酸和生物资源,2013,35(3):58-62. 被引量:2
  • 2武军,张桂欣,顾笑梅.羊水过少分娩方式的探讨[J].中国妇幼保健,2007,22(30):4310-4311. 被引量:12
  • 3Luisi S, Florio P,Reis F M, et al. Expression and secretion ofactivin A: possible physiological and clinical implications [J]. Eur JEndocrinol, 2001, 145(3): 225—236.
  • 4Molloy C J, Taylor D S, Pawlowski J E. Novel cardiovascularactions of t he activins[J]. J Endocrinol, 1999,161(2) : 179—185.
  • 5Abe M, Shintani Y,Eto Y, et al. Interleukin21 beta enhancesand interferon gamma suppresses activin A actions by reciprocallyregulating activin A and follistatin secretion from bone marrowstromal fibroblastsjj]. Clin Exp Immunol, 2001, 126(1): 64—68.
  • 6Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptiveimmunity in the pat hogenesis of at herosclerosisfj]. Circ Res,2002, 91(4): 281-291.
  • 7Libby P, Aikawa M. Stabilization of at herosclerotic plaques: newmechanisms and clinical targets [J]. Nat Med, 2002,8 (11):1257-1262.
  • 8Libb P, Ridker P M, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002(105): 1135-1143.
  • 9Kozaki K. Ouchi Y. Activin/foilistatin and atherosclerosis—a re—view|J]. Atheroscler Thomb 1998, 5(1): 36-40.
  • 10Phillips D J, Jones K L, McGaw D J, et ai. Release of activinand follistatin during cardiovascular procedures is largely due toheparin administrationQ]. Clin Endocmol Metab, 2000,85(7):2411-2415.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部